Wolfgang Wienand

Wolfgang Wienand is the CEO of Lonza, a leading global contract manufacturer of pharmaceuticals. Under his leadership, Lonza has emphasized its ability to pass on potential tariffs from the U.S. to its pharmaceutical clients, which could impact drug pricing in the U.S. market. The company has also made significant investments to expand its manufacturing capabilities, including a recent acquisition of a biotech facility in California.